Denali Therapeutics’ AVLAYAH Wins 2026 Prix Galien USA Award
Denali Therapeutics said AVLAYAH (tividenofusp alfa-eknm) was named the Galien Foundation’s “Best Biotechnology Product” of 2026.
Denali Therapeutics said AVLAYAH (tividenofusp alfa-eknm) was named the Galien Foundation’s “Best Biotechnology Product” of 2026.